Evidence map›Paper›PMID 32060556›Full record

ArticleThe Journal of clinical endocrinology and metabolism2020

Loss-of-Function Variants in TBC1D32 Underlie Syndromic Hypopituitarism.

Johanna Hietamäki, Louise C Gregory, Sandy Ayoub, Anna-Pauliina Iivonen, Kirsi Vaaralahti, Xiaonan Liu, Nina Brandstack, Andrew J Buckton, Tiina Laine, Johanna Känsäkoski and 6 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Loss-of-Function Variants in TBC1D32 Underlie Syndromic Hypopituitarism.The Journal of clinical endocrinology and metabolism · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Johanna HietamäkiPediatric Research Center, Helsinki University Hospital, New Children's Hospital, Pediatric Research Center, Helsinki, Finland.
Louise C GregoryGenetics and Genomic Medicine Programme, UCL Great Ormond Street Institute of Child Health, London, UK.
Sandy AyoubNorth West Thames Regional Genetic Service, London North West University Healthcare NHS Trust, Harrow, UK.
Anna-Pauliina IivonenDepartment of Physiology, Medicum Unit, and Translational Stem Cell Biology and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Kirsi VaaralahtiDepartment of Physiology, Medicum Unit, and Translational Stem Cell Biology and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Xiaonan LiuInstitute of Biotechnology & HiLIFE, University of Helsinki, Helsinki, Finland.
Nina BrandstackDepartment of Radiology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Andrew J BucktonLondon North Genomic Laboratory Hub, Great Ormond Street Hospital NHS Trust, London, UK.
Tiina LainePediatric Research Center, Helsinki University Hospital, New Children's Hospital, Pediatric Research Center, Helsinki, Finland.
Johanna KänsäkoskiDepartment of Physiology, Medicum Unit, and Translational Stem Cell Biology and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Matti HeroPediatric Research Center, Helsinki University Hospital, New Children's Hospital, Pediatric Research Center, Helsinki, Finland.
Päivi J MiettinenPediatric Research Center, Helsinki University Hospital, New Children's Hospital, Pediatric Research Center, Helsinki, Finland.
Markku VarjosaloInstitute of Biotechnology & HiLIFE, University of Helsinki, Helsinki, Finland.
Emma WakelingNorth West Thames Regional Genetic Service, London North West University Healthcare NHS Trust, Harrow, UK.
Mehul T DattaniGenetics and Genomic Medicine Programme, UCL Great Ormond Street Institute of Child Health, London, UK.
Taneli RaivioPediatric Research Center, Helsinki University Hospital, New Children's Hospital, Pediatric Research Center, Helsinki, Finland.
University of Helsinki · FIHelsinki University Hospital · FIGreat Ormond Street Hospital · GBLondon North West Healthcare NHS Trust · GB

Funding

Cancer Research UKDepartment of HealthMedical Research CouncilMRF_ MRF-099-0002-RG-UCLICWellcome Trust
6 · The paper itself

Abstract

contextCongenital pituitary hormone deficiencies with syndromic phenotypes and/or familial occurrence suggest genetic hypopituitarism; however, in many such patients the underlying molecular basis of the disease remains unknown.

objectiveTo describe patients with syndromic hypopituitarism due to biallelic loss-of-function variants in TBC1D32, a gene implicated in Sonic Hedgehog (Shh) signaling.

settingReferral center. PATIENTS: A Finnish family of 2 siblings with panhypopituitarism, absent anterior pituitary, and mild craniofacial dysmorphism, and a Pakistani family with a proband with growth hormone deficiency, anterior pituitary hypoplasia, and developmental delay.

interventionsThe patients were investigated by whole genome sequencing. Expression profiling of TBC1D32 in human fetal brain was performed through in situ hybridization. Stable and dynamic protein-protein interaction partners of TBC1D32 were investigated in HEK cells followed by mass spectrometry analyses.

main outcome measuresGenetic and phenotypic features of patients with biallelic loss-of-function mutations in TBC1D32.

resultsThe Finnish patients harboured compound heterozygous loss-of-function variants (c.1165_1166dup p.(Gln390Phefs*32) and c.2151del p.(Lys717Asnfs*29)) in TBC1D32; the Pakistani proband carried a known pathogenic homozygous TBC1D32 splice-site variant c.1372 + 1G > A p.(Arg411_Gly458del), as did a fetus with a cleft lip and partial intestinal malrotation from a terminated pregnancy within the same pedigree. TBC1D32 was expressed in the developing hypothalamus, Rathke's pouch, and areas of the hindbrain. TBC1D32 interacted with proteins implicated in cilium assembly, Shh signaling, and brain development.

conclusionsBiallelic TBC1D32 variants underlie syndromic hypopituitarism, and the underlying mechanism may be via disrupted Shh signaling.

Indexed as

MutationAdaptor Proteins, Signal TransducingBiomarkersChildChild, PreschoolFemaleFollow-Up StudiesHumansHypopituitarismInfantInfant, NewbornMalePedigreePhenotypePrognosisSignal TransductionAdaptor Proteins, Signal TransducingBiomarkersTBC1D32 protein, humanciliopathyhypopituitarismretinal dystrophySonic Hedgehog signalingTBC1D32

Identifiers

PMID32060556
PMCPMC7138537
OpenAlexW3006031008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.